These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34513888)

  • 1. ARDS Patients Exhibiting a "Hyperinflammatory Anasarca" Phenotype Could Benefit From a Conservative Fluid Management Strategy.
    Xing CY; Gong WB; Yang YN; Qi XJ; Zhang S
    Front Med (Lausanne); 2021; 8():727910. PubMed ID: 34513888
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluid Management in Patients with Acute Respiratory Distress Syndrome and Diabetes Mellitus: A propensity score matched analysis of the fluid and catheter treatment trial.
    Achanta A; Hayden D; Thompson BT
    Medicine (Baltimore); 2020 Sep; 99(38):e22311. PubMed ID: 32957394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying novel clinical phenotypes of acute respiratory distress syndrome using trajectories of daily fluid balance: a secondary analysis of randomized controlled trials.
    Wu F; Shi S; Wang Z; Wang Y; Xia L; Feng Q; Hang X; Zhu M; Zhuang J
    Eur J Med Res; 2024 May; 29(1):299. PubMed ID: 38807163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluid Therapy and Acute Respiratory Distress Syndrome.
    Lee J; Corl K; Levy MM
    Crit Care Clin; 2021 Oct; 37(4):867-875. PubMed ID: 34548138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of a "Specific Population Who Could Benefit From Rosuvastatin": A Secondary Analysis of a Randomized Controlled Trial to Uncover the Novel Value of Rosuvastatin for the Precise Treatment of ARDS.
    Zhang S; Lu Z; Wu Z; Xie J; Yang Y; Qiu H
    Front Med (Lausanne); 2020; 7():598621. PubMed ID: 33335905
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of distinct clinical phenotypes of acute respiratory distress syndrome with differential responses to treatment.
    Liu X; Jiang Y; Jia X; Ma X; Han C; Guo N; Peng Y; Liu H; Ju Y; Luo X; Li X; Bu Y; Zhang J; Liu Y; Gao Y; Zhao M; Wang H; Luo L; Yu K; Wang C
    Crit Care; 2021 Aug; 25(1):320. PubMed ID: 34461969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome*.
    Grissom CK; Hirshberg EL; Dickerson JB; Brown SM; Lanspa MJ; Liu KD; Schoenfeld D; Tidswell M; Hite RD; Rock P; Miller RR; Morris AH;
    Crit Care Med; 2015 Feb; 43(2):288-95. PubMed ID: 25599463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy.
    Famous KR; Delucchi K; Ware LB; Kangelaris KN; Liu KD; Thompson BT; Calfee CS;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):331-338. PubMed ID: 27513822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liberal versus conservative fluid therapy in adults and children with sepsis or septic shock.
    Li D; Li X; Cui W; Shen H; Zhu H; Xia Y
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD010593. PubMed ID: 30536956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials.
    Sinha P; Kerchberger VE; Willmore A; Chambers J; Zhuo H; Abbott J; Jones C; Wickersham N; Wu N; Neyton L; Langelier CR; Mick E; He J; Jauregui A; Churpek MM; Gomez AD; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Delucchi KL; Liu KD; Russell JA; Matthay MA; Walley KR; Ware LB; Calfee CS
    Lancet Respir Med; 2023 Nov; 11(11):965-974. PubMed ID: 37633303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two fluid-management strategies in acute lung injury.
    ; Wiedemann HP; Wheeler AP; Bernard GR; Thompson BT; Hayden D; deBoisblanc B; Connors AF; Hite RD; Harabin AL
    N Engl J Med; 2006 Jun; 354(24):2564-75. PubMed ID: 16714767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does a conservative fluid management strategy in the perioperative management of lung resection patients reduce the risk of acute lung injury?
    Evans RG; Naidu B
    Interact Cardiovasc Thorac Surg; 2012 Sep; 15(3):498-504. PubMed ID: 22617510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study.
    Sinha P; Calfee CS; Cherian S; Brealey D; Cutler S; King C; Killick C; Richards O; Cheema Y; Bailey C; Reddy K; Delucchi KL; Shankar-Hari M; Gordon AC; Shyamsundar M; O'Kane CM; McAuley DF; Szakmany T
    Lancet Respir Med; 2020 Dec; 8(12):1209-1218. PubMed ID: 32861275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis.
    Silversides JA; Major E; Ferguson AJ; Mann EE; McAuley DF; Marshall JC; Blackwood B; Fan E
    Intensive Care Med; 2017 Feb; 43(2):155-170. PubMed ID: 27734109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal phenotypes in patients with acute respiratory distress syndrome: a multi-database study.
    Chen H; Yu Q; Xie J; Liu S; Pan C; Liu L; Huang Y; Guo F; Qiu H; Yang Y
    Crit Care; 2022 Nov; 26(1):340. PubMed ID: 36333766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Initial Central Venous Pressure on Outcomes of Conservative Versus Liberal Fluid Management in Acute Respiratory Distress Syndrome.
    Semler MW; Wheeler AP; Thompson BT; Bernard GR; Wiedemann HP; Rice TW;
    Crit Care Med; 2016 Apr; 44(4):782-9. PubMed ID: 26741580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis.
    Maddali MV; Churpek M; Pham T; Rezoagli E; Zhuo H; Zhao W; He J; Delucchi KL; Wang C; Wickersham N; McNeil JB; Jauregui A; Ke S; Vessel K; Gomez A; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Liu KD; Matthay MA; Ware LB; Laffey JG; Bellani G; Calfee CS; Sinha P;
    Lancet Respir Med; 2022 Apr; 10(4):367-377. PubMed ID: 35026177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.
    Dellinger RP; Levy MM; Rhodes A; Annane D; Gerlach H; Opal SM; Sevransky JE; Sprung CL; Douglas IS; Jaeschke R; Osborn TM; Nunnally ME; Townsend SR; Reinhart K; Kleinpell RM; Angus DC; Deutschman CS; Machado FR; Rubenfeld GD; Webb S; Beale RJ; Vincent JL; Moreno R;
    Intensive Care Med; 2013 Feb; 39(2):165-228. PubMed ID: 23361625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of procalcitonin on predicting the severity and prognosis in patients with early ARDS: a prospective observation study].
    Yu Z; Ji M; Hu X; Yan J; Jin Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):34-38. PubMed ID: 28459401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.